MedRxiv: Wastewater sampling in Massachusetts suggests actual COVID-19 caseload may be five times (or more) higher than individual tests indicate
This MedRxiv paper indicates a higher prevalence of COVID-19 cases than individual tests would have showed. A STAT news article reporting on the paper says that the number of cases in the community served by the wastewater treatment plant(s) was reported as 446, but analysis of the wastewater with the same technology as the individual tests (RT-PCR) suggests at least 2300 people were infected, with a small possibility that as many as 100,000 people could have had the virus. This discrepancy may relate to the lack of available individual testing; how much virus RNA is shed in the stool may vary, but previous tests suggest that stool virus is no longer infectious due to breakdown by the digestive process.
Another study from the Netherlands found SARS-COV-2 RNA in wastewater on February 6, three weeks before anyone in the country had reported a positive test. These studies are based on those done at the time of the first SARS epidemic in 2003. The company which performed the tests, Biobot, plans to expand testing to many other wastewater plants in the US. They are offering free testing for municipalities at this time.
These studies show that the virus has been spreading in communities worldwide long before anyone was tested, not a surprise considering many cases of COVID-19 are asymptomatic. Remember that studies reported in MedRxiv have not yet been peer-reviewed, so there may be methodological or other errors. Nonetheless, this particular research appears to be solid and to be the basis for wider community testing.